Press release

Redox Teams Up with OpiSafe to Provide Opioid Risk Reduction Services Across the U.S.

Sponsored by Businesswire

The opioid epidemic requires innovative approaches, and the digital
health industry is taking steps to make inroads against this crisis. Redox
today announced that it is partnering with OpiSafe
to expand the use of OpiSafe’s comprehensive pain medication management
web and mobile platform to help thousands of providers across the
country prescribe and treat pain more effectively while avoiding bad

Redox integrates the OpiSafe platform with a provider’s electronic
health record (EHR) to gather data needed to stratify risk for each
patient on the basis of morphine equivalent dosing ranges, pain and
function scores, opioid misuse risk scores, and automated Prescription
Drug Monitoring Program (PDMP) checks. This data informs clinicians if a
patient is at risk of opioid abuse before prescribing or during a
treatment. Healthcare organizations can connect to Redox once and
authorize the data they send and receive across the most extensive
interoperable network in healthcare. OpiSafe offers thousands of
healthcare providers, pharmacies, public health departments, first
responders, and government agencies tools to manage opioid patients and
overdose response.

Every day, more than 130 people in the United States die after
overdosing on opioids.
The Centers for Disease Control and Prevention estimates that the total
“economic burden” of prescription opioid misuse alone in the United
States is $78.5 billion a year, including the costs of healthcare, lost
productivity, addiction treatment and criminal justice involvement.

“At OpiSafe, our mission is to deliver state-of-the-art clinical
decision support to prescribers who consider prescribing opioids for
pain or addiction,” said Chris Ennis, co-founder and CTO. “Connecting
data available through PDMPs, urinalysis and analytics platforms to
information stored in EHRs enables prescribers to make better decisions
in less time. Redox and OpiSafe each embrace innovation as a means to
better handle pain, reduce opioid misuse and ultimately improve outcomes
for millions of Americans. Our partnership gives health systems the
ability to rapidly deploy OpiSafe within dozens of EHR instances.”

“OpiSafe is placing premium value on developing and deploying innovative
digital applications to meet the challenges of state and local opioid
responses and the need for comprehensive frameworks for tackling
substance abuse and behavioral health,” said Niko Skievaski, president
and co-founder of Redox. “With OpiSafe in thousands of health
facilities, impacting millions of patients every year, it’s critical
that information flows freely and accurately. With the Redox hub in
place, it will be easy for OpiSafe to build a network that unleashes a
huge amount of data for providers and patients.”

About OpiSafe

The award-winning OpiSafe platform was designed to comprehensively
manage the opioid response for providers, patients, first responders and
more. Headquartered in Denver, Colo., OpiSafe serves customers in 50
states and provinces in the United States and Canada. OpiSafe partners
with a number of state and federal agencies to increase access to
state-funded prescription drug monitoring programs and lifesaving
overdose prevention tools. Learn more at

About Redox

Redox accelerates the development and distribution of healthcare
software solutions with a full-service integration platform to securely
and efficiently exchange data. Healthcare delivery organizations and
technology vendors connect once and authorize the data they send and
receive across the most extensive interoperable network in healthcare.
Redox exists to make healthcare data useful and every patient experience
a little bit better. Learn how you can leverage the Redox platform at